Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation

Annals of Clinical Microbiology and Antimicrobials

Volumn 9, Issue , 2010, Pages

  Qu, Yue ^a   Daley, Andrew J ^b   Istivan, Taghrid S ^a   Garland, Suzanne M ^b,c,d   Deighton, Margaret A ^a  

^a RMIT UNIVERSITY   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CIPROFLOXACIN; GENTAMICIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT; GROWTH INHIBITOR; SIGNAL PEPTIDE;

ADHERENT CELL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL VIABILITY; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOFILM; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EPIFLUORESCENCE MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; MONOLAYER CULTURE; NONHUMAN; SPECIES COMPARISON; STAPHYLOCOCCUS; STAPHYLOCOCCUS CAPITIS; VERY LOW BIRTH WEIGHT; BACTEREMIA; CONFOCAL MICROSCOPY; DRUG EFFECT; FLUORESCENCE MICROSCOPY; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIAL VIABILITY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NEWBORN; NEWBORN INTENSIVE CARE; PHYSIOLOGY; STAINING; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BIOFILMS; GROWTH INHIBITORS; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; POLYSACCHARIDES, BACTERIAL; STAINING AND LABELING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 77952739911     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-9-16     Document Type: Article

References (48)

1. Bansal S, Jain A, Agarwal J, Malik GK. Significance of coagulase negative staphylococci in neonates with late onset septicemia. Indian J Pathol Microbiol 2004, 47:586-588.
2. Isaacs D. A ten year multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units. Arch Dis Child >2003, 88:F89-93.
3. Cheung GY, Otto M. Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children. Curr Opin Infect Dis 2010, 23:208-216. 10.1097/QCO.0b013e328337fecb, 20179594.
4. Johnson-Robbins LA, el-Mohandes AE, Simmens SJ, Keiser JF. Staphylococcus epidermidis sepsis in the intensive care nursery: a characterization of risk associations in infants < 1,000 g. Biol Neonate 1996, 69:249-256. 10.1159/000244318, 8724653.
5. Maas A, Flament P, Pardou A, Deplano A, Dramaix M, Struelens MJ. Central venous catheter-related bacteraemia in critically ill neonates: risk factors and impact of a prevention programme. J Hosp Infect 1998, 40:211-224. 10.1016/S0195-6701(98)90139-6, 9830592.
6. von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002, 2:677-685. 10.1016/S1473-3099(02)00438-3, 12409048.
7. Klingenberg C, Aarag E, Ronnestad A, Sollid JE, Abrahamsen TG, Kjeldsen G, Flaegstad T. Coagulase-negative staphylococcal sepsis in neonates. Association between antibiotic resistance, biofilm formation and the host inflammatory response. Pediatr Infect Dis J 2005, 24:817-822. 10.1097/01.inf.0000176735.20008.cd, 16148849.
8. Otto M. Staphylococcal biofilms. Curr Top Microbiol Immunol 2008, 322:207-228. full_text, 2777538, 18453278.
9. Qin Z, Ou Y, Yang L, Zhu Y, Tolker-Nielsen T, Molin S, Qu D. Role of autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis. Microbiology 2007, 153:2083-2092. 10.1099/mic.0.2007/006031-0, 17600053.
10. Sutherland IW. The biofilm matrix--an immobilized but dynamic microbial environment. Trends Microbiol 2001, 9:222-227. 10.1016/S0966-842X(01)02012-1, 11336839.
11. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322. 10.1126/science.284.5418.1318, 10334980.
12. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004, 2:95-108. 10.1038/nrmicro821, 15040259.
13. Monzon M, Oteiza C, Leiva J, Lamata M, Amorena B. Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagn Microbiol Infect Dis 2002, 44:319-324. 10.1016/S0732-8893(02)00464-9, 12543535.
14. Nishimura S, Tsurumoto T, Yonekura A, Adachi K, Shindo H. Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases. J Orthop Sci 2006, 11:46-50. 10.1007/s00776-005-0968-7, 16437348.
15. Anderson GG, O'Toole GA. Innate and induced resistance mechanisms of bacterial biofilms. Curr Top Microbiol Immunol 2008, 322:85-105. full_text, 18453273.
16. Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 2002, 292:107-113. 10.1078/1438-4221-00196, 12195733.
17. Spoering AL, Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 2001, 183:6746-6751. 10.1128/JB.183.23.6746-6751.2001, 95513, 11698361.
18. Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, Oliveira R, Azeredo J. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 2005, 56:331-336. 10.1093/jac/dki217, 1317301, 15980094.
19. Aaron SD, Ferris W, Ramotar K, Vandemheen K, Chan F, Saginur R. Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. J Clin Microbiol 2002, 40:4172-4179. 10.1128/JCM.40.11.4172-4179.2002, 139693, 12409393.
20. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999, 37:1771-1776. 84946, 10325322.
21. Melchior MB, Fink-Gremmels J, Gaastra W. Comparative assessment of the antimicrobial susceptibility of Staphylococcus aureus isolates from bovine mastitis in biofilm versus planktonic culture. J Vet Med B Infect Dis Vet Public Health 2006, 53:326-332.
22. Mizunaga S, Kamiyama T, Fukuda Y, Takahata M, Mitsuyama J. Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems. J Antimicrob Chemother 2005, 56:91-96. 10.1093/jac/dki163, 15890721.
23. Ceri H, Olson M, Morck D, Storey D, Read R, Buret A, Olson B. The MBEC Assay System: multiple equivalent biofilms for antibiotic and biocide susceptibility testing. Methods Enzymol 2001, 337:377-385. 10.1016/S0076-6879(01)37026-X, 11398443.
24. Moskowitz SM, Foster JM, Emerson J, Burns JL. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 2004, 42:1915-1922. 10.1128/JCM.42.5.1915-1922.2004, 404629, 15131149.
25. Kumon H. Management of biofilm infections in the urinary tract. World J Surg 2000, 24:1193-1196. 10.1007/s002680010203, 11071460.
26. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) 2005, 70:267-274. 10.1007/s10541-005-0111-6, 15807669.
27. Lewis K. Multidrug tolerance of biofilms and persister cells. Currt Top Microbiol Immunol 2008, 322:107-131.
28. Pettit RK, Weber CA, Kean MJ, Hoffmann H, Pettit GR, Tan R, Franks KS, Horton ML. Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother 2005, 49:2612-2617. 10.1128/AAC.49.7.2612-2617.2005, 1168683, 15980327.
29. Qu Y, Istivan TS, Daley AJ, Rouch DA, Deighton MA. Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. J Med Microbiol 2009, 58:442-450. 10.1099/jmm.0.006387-0, 19273639.
30. Cerca N, Martins S, Sillankorva S, Jefferson KK, Pier GB, Oliveira R, Azeredo J. Effects of growth in the presence of subinhibitory concentrations of dicloxacillin on Staphylococcus epidermidis and Staphylococcus haemolyticus biofilms. Appl Environ Microbiol 2005, 71:8677-8622. 10.1128/AEM.71.12.8677-8682.2005, 1317332, 16332862.
31. Rachid S, Ohlsen K, Witte W, Hacker J, Ziebuhr W. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother 2000, 44:3357-3363. 10.1128/AAC.44.12.3357-3363.2000, 90205, 11083640.
32. Rupp ME, Hamer KE. Effect of subinhibitory concentrations of vancomycin, cefazolin, ofloxacin, L-ofloxacin and D-ofloxacin on adherence to intravascular catheters and biofilm formation by Staphylococcus epidermidis. J Antimicrob Chemother 1998, 41:155-161. 10.1093/jac/41.2.155, 9533456.
33. Bradford R, Abdul Manan R, Daley AJ, Pearce C, Ramalingam A, D'Mello D, Mueller Y, Uahwatanasakul W, Qu Y, Grando D, Garland S, Deighton M. Coagulase-negative staphylococci in very-low-birth-weight infants: inability of genetic markers to distinguish invasive strains from blood culture contaminants. Eur J Clin Microbiol Infect Dis 2006, 25:283-290. 10.1007/s10096-006-0130-2, 16598472.
34. Miyake Y, Fujiwara S, Usui T, Suginaka H. Simple method for measuring the antibiotic concentration required to kill adherent bacteria. Chemotherapy 1992, 38:286-290. 10.1159/000239015, 1286571.
35. Deighton MA, Capstick J, Domalewski E, van Nguyen T. Methods for studying biofilms produced by Staphylococcus epidermidis. Methods Enzymol 2001, 336:177-195. 10.1016/S0076-6879(01)36589-8, 11403072.
36. Villain-Guillot P, Gualtieri M, Bastide L, Leonetti JP. In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 2007, 51:3117-3121. 10.1128/AAC.00343-07, 2043205, 17606690.
37. Gualtieri M, Bastide L, Villain-Guillot P, Michaux-Charachon S, Latouche J, Leonetti JP. In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms. J Antimicrob Chemother 2006, 58:778-783. 10.1093/jac/dkl314, 16880176.
38. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. CLSI document M7-A7, approved standard. 2004, Wayne, PA; CLSI, 7, Clinical and Laboratory Standards Institute (CLSI).
39. Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, . (ed) Manual of Clinical Microbiology. 2007, Washington, D. C.: ASM Press, (ed).
40. Villari P, Sarnataro C, Iacuzio L. Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period. J Clin Microbiol 2008, 38:1740-1746.
41. Labthavikul P, Petersen PJ, Bradford PA. In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model. Antimicrob Agents Chemother 2003, 47:3967-3969. 10.1128/AAC.47.12.3967-3969.2003, 296180, 14638511.
42. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002, 8:881-890. 2732559, 12194761.
43. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985, 22:996-1006. 271866, 3905855.
44. Otto M. Virulence factors of the coagulase-negative staphylococci. Front Biosci 2004, 9:841-863. 10.2741/1295, 14766414.
45. Edmiston CE, Goheen MP, Seabrook GR, Johnson CP, Lewis BD, Brown KR, Towne JB. Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices. Am J Surg 2006, 192:344-354. 10.1016/j.amjsurg.2006.04.009, 16920429.
46. Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 2003, 47:3407-3414. 10.1128/AAC.47.11.3407-3414.2003, 253758, 14576095.
47. Moretro T, Hermansen L, Holck AL, Sidhu MS, Rudi K, Langsrud S. Biofilm formation and the presence of the intercellular adhesion locus ica among staphylococci from food and food processing environments. Appl Environ Microbiol 2003, 69:5648-5655. 10.1128/AEM.69.9.5648-5655.2003, 194930, 12957956.
48. Goller CC, Romeo T. Environmental influences on biofilm development. Curr Top Microbiol Immunol 2008, 322:37-66. full_text, 18453271.